Cederquist advisor to the financing banks in connection with Karo Pharma’s acquisition of a product portfolio from LEO Pharma A/S

Cederquist represented the lenders in connection with Karo Pharma’s acquisition of a product portfolio with an aggregate value of MEUR 260 from the Danish pharmaceutical company LEO Pharma A/S.

The acquisition will be funded through a combination of new loans and a new issue. Karo Pharma is a specialty pharmaceutical company that develops and markets products to pharmacies and to healthcare.

Cederquist’s financing team consisted of partner Johan Lundberg and associates Joachim Strand and Nils Mansfeld. Partner Fredrik Lundén and associate Louise Génetay assisted in relation to certain capital markets related matters.

For further information, please refer to the press release made public by Karo Pharma.

 

Ring
Svenska
Meny